2022-01-26 06:46:22 SMBK SmartFinancial
01/26/22 01/2606:46 01/26/2206:46 | SmartFinancial price target raised to $33 from $30 at Raymond JamesRaymond James analyst William Wallace raised the firm's price target on SmartFinancial to $33 from $30 and keeps a Strong Buy rating on the shares. SmartFinancial's Q4 results beat consensus expectations, with core loan growth accelerating and core margin coming in above estimates, Wallace tells investors in a research note. The analyst believes multiples should continue to expand as management executes successfully on its growth strategy in 2022 and 2023, and sees the risk/reward dynamic as very attractive. |
---|
General news
| Treasury Market Summary:… Story temporarily locked. ShowHide Related Items >><<
|
Syndicate
|
SuperCom files to sell 5.65M ordinary shares for holders
17:39 05/27/22 05/2717:39 05/27/2217:39
SPCB
SuperCom
ShowHide Related Items >><<
|
Syndicate
|
Olympic Steel files $200M mixed securities shelf
17:38 05/27/22 05/2717:38 05/27/2217:38
ZEUS
Olympic Steel
ShowHide Related Items >><<
|
Syndicate
|
Rain Therapeutics files automatic mixed securities shelf
17:37 05/27/22 05/2717:37 05/27/2217:37
RAIN
Rain Therapeutics
ShowHide Related Items >><<
|
Hot Stocks
| Akerna announced that the… Akerna announced that the company is implementing a plan to reduce its workforce and operating costs in order to focus its resources, accelerate its path to profitability, and create stakeholder value. The company anticipates reporting $690,000 in total costs in its second quarter to implement the reduction in force, including the following cost elements: $630,000 in severance and associated payroll taxes; $40,000 in legal costs; and $20,000 in employee insurance benefits. Of the total cost, $440,000 in salaries, payroll taxes and benefits costs would have been reported in its second quarter if the reduction in force had not been implemented. "Our sales performance in 2022 has thus far met our expectations. We believe we are showing signs of progress with revenue now at a run rate of $27m at last filing," commented Jessica Billingsley, Akerna's Chief Executive Officer. "While we believe we can continue to grow revenue and continue to reduce expenses over time, we have made the decision to focus our initiatives on our enterprise business and new market expansion of our SMB business, at least until the market conditions and the regulatory environment are in more favorable territory. We can see a path to positive cash flows and profitability, and the board and the management team are committed to getting there on an accelerated timetable. While we continue to deal with liquidity concerns, our headcount reduction and additional cost savings measures represent a material annual cost savings. As part of this restructure, executive leadership team has also collectively agreed to a 25% reduction in salary to help support the company's cost savings initiatives. As we noted on our last earnings call, bookings have been strong and our CARR is $21.1 million, and we are looking to continue to grow our top-line through a combination of enterprise wins as well as the opportunity we see in new market expansion from the SMB side of the business," added Ms. Billingsley. ShowHide Related Items >><<
|
Hot Stocks
|
Northrop Grumman awarded $254.42M Navy contract modification »
17:21 05/27/22 05/2717:21 05/27/2217:21
NOC
Northrop Grumman
Northrop Grumman was… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
Raytheon Technologies awarded $624.6M Army contract modification »
17:17 05/27/22 05/2717:17 05/27/2217:17
RTX
Raytheon Technologies
Raytheon was awarded a… Raytheon was awarded a $624.6M modification to contract for the procurement of Stinger missiles and associated equipment. Work locations and funding will be determined with each order, with an estimated completion date of June 30, 2026. U.S. Army Contracting Command is the contracting activity. ShowHide Related Items >><<
|
Syndicate
|
Entera Bio files to sell 3.76M ordinary shares for holders
17:13 05/27/22 05/2717:13 05/27/2217:13
ENTX
Entera Bio
ShowHide Related Items >><<
|
Syndicate
|
Entera Bio files $100M mixed securities shelf
17:10 05/27/22 05/2717:10 05/27/2217:10
ENTX
Entera Bio
ShowHide Related Items >><<
|
Hot Stocks
|
Range Resources CFO sells $1.8M in common stock »
17:08 05/27/22 05/2717:08 05/27/2217:08
RRC
Range Resources
In a regulatory filing,… Story temporarily locked. ShowHide Related Items >><<
|
Syndicate
|
Immix Biopharma files to sell 1.68M shares of common stock »
17:03 05/27/22 05/2717:03 05/27/2217:03
IMMX
Immix Biopharma
ThinkEquity acted as sole… ThinkEquity acted as sole book running manager for the offering. ShowHide Related Items >><<
|
On The Fly
|
What You Missed On Wall Street On Friday »
16:39 05/27/22 05/2716:39 05/27/2216:39
GPS
Gap
Workday
Ulta Beauty
Dell Technologies
Costco
Boot Barn
Zscaler
Marvell
Big Lots
Siga Technologies
Macy's
iQIYI
UnitedHealth
Canopy Growth
Reckitt Benckiser
Navient
SoFi Technologies
Nelnet
Sallie Mae
Didi
Tesla
Farfetch
PMV Pharmaceuticals
Iovance Biotherapeutics
Mirati Therapeutics
Wendy's
Hibbett
Get caught up quickly on… ShowHide Related Items >><<
|
Syndicate
|
Metalla Royalty & Streaming announces updated at-the-market program for $50M »
16:37 05/27/22 05/2716:37 05/27/2216:37
MTA
Metalla Royalty & Streaming
Metalla Royalty &… Metalla Royalty & Streaming is pleased to announce that it has entered into a new equity distribution agreement with a syndicate of agents including BMO Nesbitt Burns Inc., PI Financial Corp., and Scotia Capital Inc., as the Canadian agents, and BMO Capital Markets Corp. and Scotia Capital Inc., as the United States agents, for a new at-the-market equity program. The Distribution Agreement will allow the Company to distribute up to $50 million of common shares of the Company under the 2022 ATM Program. The Offered Shares will be issued by the Company to the public from time to time, through the Agents, at the Company's discretion. The Offered Shares sold under the 2022 ATM Program, if any, will be sold at the prevailing market price at the time of sale. ShowHide Related Items >><<
|
Initiation
|
BNP Paribas initiated with Not Rated at Goldman Sachs »
16:37 05/27/22 05/2716:37 05/27/2216:37
BNPQY
BNP Paribas
Goldman Sachs analyst… Story temporarily locked. ShowHide Related Items >><<
|
Initiation
|
Societe Generale initiated with a Neutral at Goldman Sachs »
16:36 05/27/22 05/2716:36 05/27/2216:36
SCGLY
Societe Generale
Goldman Sachs analyst… Goldman Sachs analyst Chris Hallam initiated coverage of Societe Generale with a Neutral rating and EUR 35 price target. The analyst believes the company "should see growth supported in the coming years by higher interest rates in the traditional banking business and elevated activity levels in Global Markets," however he adds that the company is "not as geared to rates as peers, consensus estimates already imply Global Markets revenue targets will be exceeded and Boursorama's success will make a relatively small impact at a group level over 2023/24." ShowHide Related Items >><<
|
Hot Stocks
|
JinkoSolar subsidiary signs new distribution agreement in Latin America »
16:35 05/27/22 05/2716:35 05/27/2216:35
JKS
JinkoSolar
JinkoSolar announced that… Story temporarily locked. ShowHide Related Items >><<
|
Hot Stocks
|
China Green discloses NYSE notice regarding late 10-Q filing »
16:35 05/27/22 05/2716:35 05/27/2216:35
CGA
China Green
China Green… China Green "announced that, as a result of its failure to file its Quarterly Report on Form 10-Q for the period ended March 31, 2022 in a timely fashion, it has received a notice from the New York Stock Exchange that the Company was not in compliance with the NYSE's continued listing requirements under the timely filing criteria established in Section 802.01E of the NYSE Listed Company Manual. As reported by the Company in its Form 12b-25 filed with the Securities and Exchange Commission on May 17, 2022, the Company was unable to file the Form 10-Q within the prescribed time period without unreasonable effort or expense. The extension period provided under Rule 12b-25 expired on May 23, 2022. The Company is unable to meet the filing deadline for the filing of its Form 10-Q due to circumstances related to COVID-19. In the year of 2022, more pandemic restrictions had been tightened throughout China to control the spread of COVID-19 in the community. As the Company's primary business is in China, its operations had been impacted due to the pandemic restrictions. The Company is currently working closely with its principal accounting firm to complete the filing of its Form 10-Q as soon as reasonably practicable." ShowHide Related Items >><<
|
Initiation
|
Credit Agricole initiated with a Neutral at Goldman Sachs »
16:34 05/27/22 05/2716:34 05/27/2216:34
CRARY
Credit Agricole
Goldman Sachs analyst… Story temporarily locked. ShowHide Related Items >><<
|
Syndicate
|
Bio-Path files $110M mixed securities shelf
16:32 05/27/22 05/2716:32 05/27/2216:32
BPTH
Bio-Path
ShowHide Related Items >><<
|
Initiation
|
UniCredit initiated with a Buy at Goldman Sachs »
16:32 05/27/22 05/2716:32 05/27/2216:32
UNCRY
UniCredit
Goldman Sachs analyst… Story temporarily locked. ShowHide Related Items >><<
|
Initiation
|
Intesa Sanpaolo initiated with a Buy at Goldman Sachs »
16:30 05/27/22 05/2716:30 05/27/2216:30
ISNPY
Intesa Sanpaolo
Goldman Sachs analyst… Goldman Sachs analyst Chris Hallam initiated coverage of Intesa Sanpaolo with a Buy rating and EUR 3.25 price target. The analyst believes that the recent move in interest rates is "set to drive higher-than-expected NII and group revenues, more than offsetting pressure on fees from lower asset values." ShowHide Related Items >><<
|
Options
| Preliminary option volume… Story temporarily locked. |
Hot Stocks
|
Nvidia recommends shareholders reject 'mini-tender' offer from Tutanota »
16:29 05/27/22 05/2716:29 05/27/2216:29
NVDA
Nvidia
Nvidia announced that it… Nvidia announced that it recently became aware of an unsolicited "mini-tender" offer by Tutanota to purchase up to 215,000 shares of Nvidia common stock, representing significantly less than 1% of Nvidia's outstanding common stock. The offer price of $210 per share is conditioned on, among other things, the closing price per share of Nvidia's common stock exceeding $210 per share on the last trading day before the offer expires. This means that unless Tutanota waives this condition, Nvidia stockholders who tender their shares in the offer will receive a below-market price. Nvidia cautions stockholders that Tutanota has stated it expects to extend the offer for successive periods of 45 to 180 days, in which case payment would be delayed beyond the scheduled expiration date of Friday, May 27. There is no guarantee that the conditions of the offer will be satisfied. Nvidia recommends that stockholders do not tender their shares in response to Tutanota's offer because the offer requires that the closing price per share of Nvidia's common stock exceed the offer price, and the offer is subject to numerous additional conditions, including Tutanota obtaining financing for the offer. Stockholders who have already tendered their shares may withdraw them at any time by providing notice in accordance with the Tutanota offering documents prior to the expiration of the offer, which is currently scheduled for 5 p.m. Eastern Daylight Time on Friday, May 27. ShowHide Related Items >><<
|
Hot Stocks
|
Renren signs amendment to stipulation of shareholder derivative settlement »
16:23 05/27/22 05/2716:23 05/27/2216:23
RENN
Renren
Renren announced that it… Story temporarily locked. ShowHide Related Items >><<
|
Syndicate
|
GCM Grosvenor files $350M mixed securities shelf
16:20 05/27/22 05/2716:20 05/27/2216:20
GCMG
GCM Grosvenor
ShowHide Related Items >><<
|